Motion sickness is a disorder that arises often as a response to real or perceived movement, as occurring during travel. Vomiting is the most disturbing symptom of motion sickness, although the disorder is often accompanied by a constellation of symptoms that includes nausea, sweating, pallor, headache and anorexia.

The global Motion Sickness Treatment market was valued to be 438 million USD in 2020 with a CAGR of -8.63% during 2016 and 2020. The sharp decline of the market size in 2020 is caused by travel restrictions due to COVID-19. The Motion Sickness Treatment market size is anticipated to have grown with a CAGR of 8.12% in the coming years to reach 698 million USD in 2026.

North America and Europe is the largest market which occupies 59.5% and 25.9% market share respectively. Diphenhydramine, Dimenhydrinate and Scopolamine are the most important drugs for motion sickness treatment. Here is the chart of their market share.